Cravath represented Mylan Inc. in connection with its €500 million Reg. S senior notes offering. Mylan N.V. is a leading global pharmaceutical company that develops, licenses,…
Mylan Inc.’s €500 Million Senior Notes Offering

Cravath represented Mylan Inc. in connection with its €500 million Reg. S senior notes offering. Mylan N.V. is a leading global pharmaceutical company that develops, licenses,…